Questionnaire, strength, muscle mass and gait, as in the European consensus.
Details
Step 1 · SARC-F questionnaire
Step 2 · Strength
Fill in at least one: grip strength (best attempt, stronger hand) or the time to stand up 5 times from a chair without using your arms.
Step 3 · Muscle mass (optional)
Only if you have a DXA or bioimpedance measurement: appendicular skeletal muscle mass (ASM) or ASM/height².
Step 4 · Gait speed (optional)
Time to walk the given distance at your usual pace (usually 4 m).
How the test works
The test follows the four steps of the European EWGSOP2 consensus (Find-Assess-Confirm-Severity):
- Find cases with the SARC-F questionnaire: 4 points or more indicate risk.
- Assess strength: grip below 27 kg in men or 16 kg in women, or more than 15 s in the 5-repetition chair stand test, indicate probable sarcopenia.
- Confirm with appendicular muscle mass: below 20 kg (men) or 15 kg (women), or below 7.0 / 5.5 kg/m².
- Grade severity with physical performance: gait speed of 0.8 m/s or less indicates severe sarcopenia.
Full explanation in how sarcopenia is measured.
How to do the tests at home or in clinic
- Grip: seated, elbow at 90°, three attempts per hand with a dynamometer; use the best (normal values).
- Chair stand: arms crossed, stand up and sit down 5 times as fast as possible (how to do it).
- Gait: 4 metres at usual pace, timed (gait speed).
Measuring it precisely
Wellness Bench sensorises grip, the chair stand test and other functional tests, calculates muscle age and sarcopenia risk and produces a report in under five minutes. To measure grip only, HandGrip.
Frequently asked questions
How do I know if I have sarcopenia?
The SARC-F questionnaire detects risk; then strength is measured (grip or chair stand test). If it is low, sarcopenia is probable and a professional confirms it by measuring muscle mass.
What is the SARC-F questionnaire?
Five questions on strength, walking assistance, rising from a chair, climbing stairs and falls. Each scores 0 to 2; 4 points or more indicate sarcopenia risk.
Which cut-off points does the test use?
Those of the European EWGSOP2 consensus: grip below 27 kg (men) or 16 kg (women), chair stand test over 15 s, appendicular muscle mass below 20 or 15 kg and gait speed of 0.8 m/s or less.
Does this test replace a medical diagnosis?
No. It is for guidance only; diagnosis is made by a healthcare professional.
References
- Cruz-Jentoft AJ et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing, 2019.
- Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc, 2013.
- Kirk B et al. The conceptual definition of sarcopenia: Delphi consensus from the Global Leadership Initiative in Sarcopenia (GLIS). Age and Ageing, 2024.
- Bohannon RW. Grip strength: an indispensable biomarker for older adults. Clinical Interventions in Aging, 2019.


